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Aruba is a small island belonging to the Lesser Antilles in the Caribbean Sea just north of Venezuela (South America). This Island along with its sister islands Bonaire and Curacao (the ABC islands) are part of the kingdom of the Netherlands. Aruba is located at 12°19’N 70°1’W and has an isothermal temperature of about 28°C. Because of its high temperatures in combination with the high relative humidity during the rainy season, ticks are present in large numbers among stray dogs as well as domestic dogs. Speaking to local veterinarians, you come to find out that a big part of their daily work revolves around the control of ticks and the treatment of diseases transmitted by ticks. In dogs, Ehrlichia canis is suspected to be the main disease transmitted by ticks on Aruba.   
In 2008 a survey was done on Aruba by van Straten, in this survey 100 blood samples were taken from neglected dogs and tested serologically for E.canis antibodies, the same samples were also tested for E.canis antigen by PCR amplification. Out of these 100 samples 14 were infected with E.canis and 58 of them were serologically positive for E.canis antibodies. In the same survey ticks were removed from the neglected dogs and identified, all identifiable ticks were Rhipicephalus sanguineus ticks known to be able to spread E.canis (Straten, G., 2008). 
Because Aruba is part of the Kingdom of the Netherland trafficking of dogs, either temporarily (vacation) or indefinitely (importation), from Aruba to the Netherlands happens relatively often. For the importation of a dog to the Netherlands all that is required is a certificate of good health and vaccinations that are up to date. 
Rhipicephalus sanguineus ticks are not endemic in the Netherlands, although they have been identified on animals which had previously traveled outside of the Netherlands as well as animals who had not been out of the country. In a research done by Nijhof et. al. in 2007, R.sanguineus ticks could survive and complete their life cycle indoors in the Netherlands and especially in dog kennels where the temperatures are higher (Nijhof, A.M., 2007). In another previous research by Blaauw in 2009, an analysis was done on 1200 blood samples tested for E.canis antibodies by the Veterinary Microbiological Diagnostic Centre (VMDC) at the University of Utrecht. The 1200 samples were sent in by Veterinary practices in the Netherlands and Belgium during the period of January 2003 until May of 2008. Out of these 1200 blood samples, 162 samples (13.15%) were positive for E.canis antibodies, 113 of these positive blood samples were from dogs living in the Netherlands. The patient history was only available for 40 of the 113 serologically positive dogs.  A total of 33 of these 40 dogs had been out of the country, 27 of which had imported a locally adopted dog and the other 6 had gone on vacation with their own dog (Blaauw, F., 2009). 
The fact that most serologically positive dogs in the Netherlands are imported, makes it important for countries like Aruba where dogs are trafficked often (vacation/import) to check for active E.canis infections. Theoretically dogs exhibiting no clinical signs after a treatment regimen for Canine monocytic Ehrlichiosis (CME) could still carry E.canis and could infect other dogs in the Netherlands. Therefore in order to prevent the importation of infected dogs and ticks into the Netherlands, the aim of this study is to establish the effectivityof the diagnostic methods used for determining CME infections in Aruba. It is also relevant to test the effectivityof the treatment regimens used for dogs with CME in Aruba, so a treated dog will be able to be transported without carrying the disease. The effectivityof diagnosis and treatment will be determined using serological testing for E.canis antibodies and Ehrlichia PCR amplification on blood samples of suspected CME patients. 








Pathogenesis and clinical symptoms
Canine monocytic Ehrlichiosis (CME) is a tick borne disease caused by the rickettsia Ehrlichia canis. Since the rickettsia E. canis was first described in Algeria in 1935 by Donatien and Lestoquard ( Donatien, A. et al. 1935), E. canis has been considered to be an important disease of mainly domestic dogs and other canids worldwide (Harrus, S. et al. 1999).  E.canis is a gram negative obligate intracellular bacteria which mainly parasitizes monocytes and macrophages, hence the name “monocytic ehrlichiosis” (Rikihisa,Y. et al. 1994).

The pathogenesis of CME is characterized by an incubation period of about 8 to 20 days followed by an acute, subclinical and sometimes chronic phase of the disease (Harrus, S. et al1999). The chronic phase of the disease does not always take place because sometimes the organism is cleared during the subclinical phase of the infection (Nelson, R. et. al. 2003). A wide variety of clinical symptoms can be seen in this disease, but the most common clinical symptoms are lethargy, weight loss, anorexia, fever, lymphadenomegaly, splenomegaly and bleeding tendencies (Harrus, S. et al1999).  

The acute phase of the disease lasts about 2-4 weeks, and is characterized by infected mononuclear cells migrating into the endothelium and inducing a vasculitis. The clinical symptoms shown as a result of this vasculitis are usually fever, serous to purulent oculonasal discharge, anorexia, weight loss, dyspnea and lymphadenopathy. Less common clinical symptoms in the acute phase are petechiae and bleeding tendencies (Nelson, R., 2003). Hematological changes in the acute phase usually include thrombocytopenia, mild anemia and a mild leucopenia. The main hematological change is the thrombocytopenia, in the acute phase this is probably due to increased platelet consumption because of defects in the endothelial wall caused by the vasculitis, increased sequestration of platelets by the spleen and immunological destruction or injury to the platelets. All these mechanism lead to a decreased platelet survival time (Harrus, S. et al1999). Studies using radioisotopes have shown that during the incubation period (2 to 4 days after infection with E.canis) platelet survival times went down from a mean of 9 days to a mean of 4 days, the main destruction of platelets occurs in the spleen (Smith, R.D. et al 1975).  
The main biochemical change in the blood in the acute phase is hypoalbuminemia, this  occurs because of third spacing of albumin into the extracellular fluid of tissues because of the increased vascular permeability caused by the vasculitis (Nelson, 2003). 

If the dog survives the acute phase of the disease, the subclinical phase follows. The subclinical phase of the disease can last months to years. In the subclinical phase E.canis can persist intracellularly for 34 months or longer, in this phase the organism can be cleared, even without treatment (Harrus et al, 1998). During this phase of the CME the dogs don’t have any clinical symptoms. The main hematological and biochemical changes in the subclinical phase are a mild thrombocytopenia, a decrease in neutrophil counts (not enough to cause a neutropenia) and hyperglobulinemia (Harrus et al, 1998) (Nelson, R., 2003). 

The conditions that lead to the development of the chronic phase from the subclinical phase of CME are still not fully understood. However it may be related to breed (German shepherds for example are more sensitive), immune status, stress conditions, co-infections with other parasites, the strain of E.canis, persistent reinfections or the geographical location ( Buhles, W.C. et al 1974).The pathogenesis of the chronic phase of CME is not fully understood either, but is usually characterized by chronic immune stimulation, pancytopenia and hyperglobulinemia (Harrus, S. et al1999). 
The chronic immune stimulation leads to splenomegaly, lymphadenopathy and hepatomegaly. Immune-complex deposition can also lead to glomerular loss which can lead to polyuria/polydipsia, proteinuria and rarely prerenal azotemia. The chronic immune stimulation in combination with thrombocytopenia also leads to exhaustion of the bone marrow which leads to the pancytopenia (Nelson,R., 2003). 
The thrombocytopenia leads to petechiae and hemorrhage. The leucopenia leads to secondary infections (intestinal, respiratory symptoms etc.). The non regenerative anemia leads pale mucous membranes and exercise intolerance. 
Other symptoms that are less common are retinitis, retinal detachment, uveitis, corneal edema, polyartritis, CNS involvement (paresis, seizures, meningeal pain) and arythmias. The chronic phase of the disease often leads to death (Nelson, R. 2003).
 
Diagnosis
There have been many publications about diagnostic methods of CME, but the most successful method has been by the PCR amplification of E. canis DNA on the blood, bone marrow or spleen of infected dogs. PCR assays are faster and easier than blood or tissue cultures which may take weeks. PCR assays may become positive within 4-10 days of exposure (Neer et al.,  2002). The PCR of E.canis DNA in the spleen has proven more successful than that of the blood or bone marrow (Harrus, S. et. al 2004).
		Serological test can be used to detect E.canis antibodies; the indirect fluorescent antibody (IFA) test is the most sensitive test that can be used. The IFA detects antibodies as soon as 7 days after infection but some dogs take 28 days before they become seropositive (Neer et. al. 2002). ELISA methods are also used in the detection of antibodies, in a study by Waner et. al. the ELISA test kit was compared with the IFA test and they seemed to be equally sensitive in the early detection of E.canis antibodies (Waner et al 2000). E.canis titers can remain high during the subclinical phase of CME for a long time, even when the organism has already been cleared; titers can remain high for 16 months or longer.(Harrus et al, 1998)
The use of serology can be effective when typical clinical signs are found in conjunction with a positive serological test. However because of latent infections during the subclinical phase or a cleared infection in the past, a positive serological test does not mean that the clinical signs are actually being caused by CME. This is especially true for endemic areas like Aruba where many healthy dogs have positive serum titers to E.canis (Neer, T. et. al. 2002) ( Straten, G., 2008). 

In the Veterinary practice of Aruba CME is usually diagnosed by the clinical symptoms presented by the patient, simple blood tests and the clinical reaction to oxytetracycline or doxycycline treatment. In the blood test the veterinarians usually settle for a simple hematocrit determination. The local veterinarians have found a recognizable correlation between dogs exhibiting CME symptoms, which react well to doxycycline and oxytetracycline treatment, and a low hematocrit. This diagnostic method is chosen because dog owners are often unwilling to pay for a full blood count (Neutropenia, thrombocytopenia) or biochemical analysis (hypoalbuminemia, Hyperglobulinemia). 




Several different treatment options have been proposed for CME, such as tetracyclines, doxycycline, chloramphenicol and imidocarb dipropionate. Tetracyclines and oxytetracyclines were considered the initial drug of choice in the past and are still effective (Neer et. al. 2002). Lately the most commonly used treatment option has been doxycycline 10mg/kg for 28 days (Harrus, et.al., 2004). The ACVIM Infectious Disease Study Group also recommends this treatment protocol because it seems to be the most effective in comparison with the other drugs mentioned (Neer et. al. 2002). The use of tetracycline or doxycycline is especially effective in the acute- or mild chronic phase where it usually resolves the clinical symptoms within 24-48 hours and resolves the thrombocytopenia within 14 days (Nelson, R. 2003). Wide ranging results have been published about the actual clearance of E. canis whilst on doxycycline treatment. It seems that the clearance of E.canis is dependant upon the phase of CME. 

In the acute phase positive results about the clearance of E.canis have been published. 
In 1998 Breithschwerdt et. al. published an article in which 8 dogs were experimentally infected with E.canis, the acutely infected dogs were treated with doxycycline hyclate (5.6-6 mg/kg twice daily) for 14 days. All 8 of these dogs were PCR negative on blood samples and negative on tissue cultures as well. It needs to be mentioned that the infected control dogs left untreated in this study also remained PCR negative and tissue culture negative (Breithschwerdt, B et. al., 1998). In another similar study in 2004, 5 dogs were artificially infected and were treated on day 12 post infection when all dogs had become severely ill. The dogs were treated with doxycycline hydrochloride 10 mg/kg/day for 60 consecutive days.  At 16 days post treatment all dogs had negative PCR results for blood and spleen samples. This study suggests the possibility of lowering the recommended treatment protocol from 28 days to 16 days (Harrus et. al. 2004).  

In the subclinical phase even longer treatment protocols have been tried unsuccessfully. 
In a study by Harrus et. al . in 1998, 4 clinically healthy dogs which were PCR positive for E.canis at 34 months post infection were treated with doxycycline10 mg/kg/day for 42 days. At the end of the treatment protocol the blood sample of 1 of the 4 dogs remained PCR positive (Harrus, S. et al, 1998). In another study done by Iqbal and Rikihisa in 1994 five dogs not showing any clinical signs at 2 months post infection were treated with doxycycline 10 mg/kg/day for 7 days. Three of the five dogs remained positive for E.canis in tissue culture isolation. 

Until now there have been very few publications about the effect of CME treatment in the chronic phase. In one study done in 1974, nine German shepherd dogs developed severe chronic tropical canine pancytopenia (TCP) (CME was then still called TCP). German shepherds are known to be very sensitive to CME and develop the chronic phase very quickly. These dogs were treated orally with Tetracycline hydrochloride at 30 mg/lb/day for 14 days. Back then this treatment protocol was used effectively for resolving the clinical symptoms and hematological changes caused by the acute phase of CME. For at least the first 120 days after the treatment had begun, neither the leucopenia or the thrombocytopenia had resolved for any of the surviving dogs in the chronic phase of CME. Six of the nine dogs also remained anemic (Buhles, et. al. 1974). The treatment used back then seems to be ineffective but there is very little evidence to prove whether or not the treatment protocols nowadays can clear an E.canis infection in the chronic phase. 


2.2	Relevance of Rhipicephalus sanguineus in CME

All currently defined Ehrlichia species are biologically transmitted by ticks of the Ixodidae family (Bremer, W.G. et al 2005). Until now the ticks that have been identified to be able to transmit E.canis, are Rhipicephalus sanguineus (Groves, M.G. et al. 1975) and Dermacentor variabilis (Johnson, et. al. 1998). In 2008 a survey was done by van der Straten on the Island of Aruba, here 4237 ticks were collected from 100 neglected dogs. All the ticks that could be determined were identified as Rhipicephalus sanguineus ticks. In the same survey blood samples were taken from the neglected dogs and tested for E.canis, 28 dogs had a positive Ehrlichia/Anaplasma catch all signal on the Reverse line blot. Half of those dogs which were positive for the Ehrlichia/Anaplasma catch all signal had a positive E.canis signal, so at least 14% of the dogs tested were infected with E.canis (Straten van der, G. 2008). This is why knowledge about Rhipicephalus sanguineus tick life cycle and transmission of E.canis is an integral part of the control of CME on Aruba. 

Rhipicephalus sanguineus life cycle
Rhipicephalus sanguineus (R. sanguineus) ticks are three-host ticks; they are characterized by feeding once during every active developmental stage, the ticks need to feed in order to develop. After hatching from the eggs larvae will feed once (3-10 days), fall off the dog and molt into a nymph (5-15 days) in the environment, in turn the nymph will repeat that process (feed 3 -11 days) and develop into an adult in the environment (9-47 days). Once the tick has developed into an adult female, she can climb on a host and copulate. Once she has copulated the female can feed for 5-21 days, once the engorgement is complete she detaches from the host and will lay her eggs and die in a sheltered place in the environment, this mostly occurs near the host’s resting place. Adult males can climb onto the host and copulate with the female, once the male has copulated; the male usually stays on the host and mates with other females (Dantas-Torres, F. 2008).Unlike females adult male ticks can feed and drop off a host without having to copulate/reproduce, so males have the ability to feed on multiple hosts during their adult life (Bremer W.G. et al. 2005).

Transmission of E.canis by R.sanguineus ticks
It has been proven that Rhipicephalus sanguineus nymphs or adults can be infected with E.canis by feeding off the blood of an infected host. When the tick feeds the bacteria can multiply in the salivary gland and intestine of the tick, after multiplication the bacteria return to the salivary gland. When the tick feeds again (on the same dog or another), the salivary gland serves as the main source of infection with E.canis (Smith et al. 1976).

	Transstadial transmission of E.canis by R. sanguineus ticks:
Because R.sanguineus ticks are three-host ticks they can infect many different dogs transstadially. Although all three feeding stages (larvae, nymphs and adults) are known to readily attach to the canine host, only the latter two stages are known to transmit E.canis. The E.canis infection is not removed when a nymph develops into an adult; so when an E.canis infected R. sanguineus nymph develops into an adult tick, the adult tick remains infected.  So a nymph infected on a canine host can detach and fall off the host into the environment to develop into an adult, this infected adult can then infect another canine host (Bremer W.G. et al. 2005).

	Intrastadial transmission of E.canis by R. sanguineus ticks:
The adult male R.sanguineus ticks have the capability to infect multiple hosts during their adult lifespan. This is because copulation is not necessary between multiple feedings in the male ticks (Bremer W.G. et al. 2005). So it is possible for an adult male to feed off an infected host, drop to the environment and climb onto another uninfected host where he can feed again (Little et al 2007). 

Transmission of other pathogens by R. sanguineus ticks
In 2008 an article was published about R.sanguineus ticks by Dantas-Torres. In this article a list of all pathogens that are known to be or are possibly transmitted by R.sanguineus ticks was published. Some of these pathogens are really relevant in the spread of disease among canines, to name a few:  Ehrlichia canis, Babesia canis, Babesia gibsoni, Anaplasma platys, Hepatozoon canis and possibly Leishmania infantum, the latter has not been proven yet (Dantas-Torres 2008). 
Babesia canis infections in dogs often cause clinical symptoms which are also quite common in Ehrlichia canis infections. For example during a Babesiosis outbreak in the Netherlands in the spring of 2004 many dogs had the same typical symptoms mentioned in CME; lethargy, anorexia, fever, anemia, thrombocytopenia, petechiae and splenomegaly (Matjila, T.P. et al, 2005). There have also been reports that tetracyclines (the drug of choice against CME) can be effective in preventing canine babesiosis (Vercammen, F. et. al. 1996). So the tetracyclines used as treatment in Aruba could also be effective against some stages of babesiosis. Canine Babesiosis has been identified in blood smears in the past, but the exact species of Babesia canis has never been determined.




3. Materials and Methods

Patient selection, Blood sample collection and Red blood cell count determintation. 
For a period of three months Veterinaire klinieken Aruba (VKA), with its three auxiliary branches, participated in this research project. Whenever a dog was suspected of carrying the disease canine monocytic ehrlichiosis (CME), the owners were notified about the research project. It was up to the owners to decide if they wanted to let their dog participate in the research. If the owner agreed to participate, the dog was examined and a checklist containing clinical symptoms frequently seen in CME was filled out by the Veterinarian (checklist in Appendix 1). If the dog was exhibiting clinical symptoms which were not mentioned in the checklist, these would be filled out under the name: other symptoms. 
For every suspected CME patient 1.5 to 2.5 ml venous blood was taken and transferred to 3ml EDTA vacutainer tubes. If the Veterinarian had already taken blood from the patient before suspecting the diagnosis CME, this blood would be used for the research. 
Some of the EDTA blood was used to determine the red blood cell count (RBC); blood was collected in a micro hematocrit collection tube and centrifuged for 60 seconds at 6060 rpm. After spinning the RBC percentage was read (a hematocrit of 37% or less was considered to be anemic). 
The remaining EDTA blood was stored at 4 degrees Celsius for a maximum of 5 days, this would later be taken to another location for serological testing and fixation on filtration paper.

For patients returning for the first and second time after the initial treatment the same process was repeated. The checklist was filled out and the blood sample was taken in the same way.

Treatment
The veterinary practice where this research was conducted uses three different treatment protocols. 
1.	The first, for puppies younger than 6 months, consists of once daily subcutaneous injections of oxytetracycline at a dose of 10 mg/kg for 5 consecutive days.  
2.	The second protocol is for dogs older than 6 months which are suspected of being infected with E.canis, with a hematocrit of 30% or more. These dogs are treated with once daily subcutaneous injections oxytetracycline at a dose of 10 mg/kg for two consecutive days followed by the administration of oral  doxycycline twice daily at a dose of 5 mg/kg every for 14 days (10 mg/kg/day). 
3.	The third protocol is for dogs older than 6 months which are suspected of being infected with E.canis, with a red blood cell count of less than 30%. These dogs are treated with once daily subcutaneous injections of oxytetracycline at a dose of 10 mg/kg for 5 days, followed by the administration oral doxycycline twice daily at a dose of 5 mg/kg for 14 days (10 mg/kg/day).

The first protocol for dogs younger than 6 months was mostly strictly followed.  The second and the third protocols were not followed as strictly, this happened because owners frequently weren’t willing to come back for 5 days of subcutaneous injections when the oral treatment was also possible. In those cases it was either chosen to give a longer oral therapy (21 days) or to just leave the oral therapy for 14 days but with fewer subcutaneous injections. 

Serological testing
The blood samples were transported from the clinic to the lab in a cool box containing an ice pack. The transportation was by car and took about 15 – 30 minutes. Once the blood arrived at the lab it was placed on a “mixer” and continuously mixed for about twenty minutes allowing the temperature of the blood to get to about room temperature. The blood was then used for the Snap® 3Dx® test according to the instructions given by its manufacturer Idexx laboratories. The Snap 3 Dx® test can be used for whole blood, serum or plasma and tests for E.canis antibodies, Borrelia Burgdoferi antibodies (Lyme disease) and Dirofilaria immitis antigen (Heartworm) simultaneously. During the second consultation the test was repeated on blood samples taken from dogs which tested negative for E.canis antibodies during the first consultation. This was done to check for any seroconversion that might have taken place. If the second blood sample was also negative the test was repeated for the third blood sample after another 4 weeks, this was done to check for new infections of E.canis.
Tests were also repeated for the second and third blood sample if dogs tested positive but were under the age of 4 months, this was done to exclude the presence of maternal antibodies to E.canis. 

Blood fixation on filter paper
Filter paper was cut up to size for every blood sample. The patient number, date of blood withdrawal and consultation number belonging to a certain blood sample was noted with a pencil on the filter paper. Following the identification, a blood spot corresponding to the right blood sample was brought on to the filter paper making sure it was at a safe distance to the pencil markings. An identical amount of blood from every blood sample was brought on to the corresponding filter paper. (4 drops of a disposable transfer pipet: about 250 µl). The bloodspots were then allowed to dry for three hours in a dry place at room temperature. After three hours the bloodspots were fixated with 100 µl methanol, and allowed to dry for another hour. Once dried the samples of filter paper were stacked and separated by a thin sheet of paper. These stacks were stored in a dry place at room temperature until they could be transported to Utrecht centre for Tick Borne Diseases where DNA extraction, PCR amplification and the Reverse line blot could take place.

DNA extraction
A NucleoSpin ® Tissue Kit protocol for dried blood spots was used (Macherey-Nagel, 03-2009). For every dried blood spot a piece of about 20-30 mm2 was cut out using a sharp sterile scalpel. The dried blood was dissolved and lysed using buffers and a Proteinase K solution mentioned in the protocol. After lyses the DNA was bound into a NucleoSpin ® tissue column by using Ethanol and washing with several buffers recommended by the protocol. After binding, the concentrated DNA was eluted using 50 µl of the recommended Elution Buffer in stead of the recommended 100 µl. This purified DNA was then collected into a 1.5 ml collection tube. 

DNA amplification
DNA amplification was done using an iCycler Thermal cycler machine manufactured by Bio-Rad. 
Every DNA sample underwent 2 different PCR reactions. The first reaction was for the amplification of possible Ehrlichia/Anaplasma DNA, and the second was for the amplification of possible Babesia/Theileria DNA. For the two separate reactions a different mix had to be used. Both mixes contained the same basic contents.
The only difference was the primers that were added to the basic mix. 
	For the Ehrlichia/Anaplasma mix, the following primers were added: Ehrlichia/Anaplasma16S-F1primer (GGA ATT CAG AGT TGG ATC MTG GYT CAG) Ehrlichia/Anaplasma 16S-R1 primer (CGG GAT CCC GAG TTT GCC GGG ACT TYT TCT)
	For the Babesia/Theileria mix, the following primers were added:
Babesia/Theileria 18S-F2 (GAC ACA GGG AGG TAG TGA CAA G)
Babesia/Theileria 18S-R2 (CTA AGA ATT TCA CCT CTG ACA GT)
	
20 µl of the each mix was used for the amplification of one sample.

For each DNA sample 5 µl of purified DNA was added to both the Ehrlichia/Anaplasma mix as well as the Babesia/Theileria mix. After this step the 25 µl mix including purified DNA was ready to be amplificated using the iCycler Thermal cycler machine. A specific program sequence was used to amplify the DNA in the iCycler, the program sequence that was run can be seen below:

1.	5 minutes at 37 °C
2.	5 minutes  at 94 °C
3.	10 repetitions  
a.	20 Seconds at 94 °C  (Denaturation)
b.	30 Seconds at 67 °C	(Annealing)
c.	30 Seconds at 72 °C	(Elongation)
4.	40 repetitions 
a.	20 Seconds at 94 °C 	(Denaturation)
b.	30 Seconds at 57 °C	(Annealing)
c.	30 Seconds at 72 °C	(Elongation)
5.	7 minutes at 72 °C
6.	Cooling at 4 °C until PCR product is removed from the Thermal cycler.

Principle:
During the repetitions DNA denaturation took place, because of the heating at the 94 °C the hydrogen bonds rupture and cause the DNA strands to split. During the short cooling step (annealing) at 67 °C the primers can then bind to the DNA strand. After this step the heating step starts to about the optimum temperature of the added DNA polymerase ( 72 °C) so the DNA polymerase can start elongating the DNA at the location of the primers. If target DNA is present in the sample, the frequent repetitions of these steps will make it possible for the primers to bind and replicate the target DNA, so this will amplify exponentially.   

Gel Electrophoresis 
After the amplification process 5 µl of the PCR product from the DNA samples were mixed with 1 µl loading dye in wells plates. The DNA mixed wit the loading dye was then loaded into slots of a solidified 1.5 % agarose gel solution. Before the 1.5 % agarose solution was solidified Ethidiumbromide was added so the DNA could later be visualized under UV-light (ethidiumbromide binds to DNA and emits fluoresesence when viewed with a UV-light source). The gel was then electrified in an electrophoresis apparatus at 100 mA for about 30-40 minutes. After 30-40 minutes the gel was taken out of the apparatus and viewed under a UV-illuminator where a picture could be taken.

Principle:




	In the bottom of the gel: DNA ladder of 100 BP (functions as a comparison for the size of tested DNA)
Blue arrow: Smaller primer DNA bundled together (traveled further to positive pole) Present in almost every DNA sample
	Green arrow: Positive control Ehrlichia and Babesia sample (Bigger bundle DNA so traveled less far than primer)
	Red arrow: Positive Babesia/Theileria sample (DNA traveled as far as the positive controle for Bab/Theileria)


Reverse Line Blot (RLB)
The RLB was performed using a standard protocol.
In the PCR amplification step primers are used to amplify all species of Ehrlichia/Anaplasma and Babesia/Theileria. The reverse line blot (RLB) is a way of differentiating between different species of target DNA. It is a method of detecting amplified DNA of more specific Ehrlichia, Babesia, Theileria or Anaplasma species present in the PCR product. The RLB is also a more sensitive method for detecting target amplified DNA products than the Gel electrophoresis

Protocol principle:
In the RLB, a membrane lined with linked probes containing oligonucleotide sequences that can bind to specific locations of amplified target DNA. Each line has a specific oligonucleotide sequence that can bind to specific pathogen DNA. The membrane that was used for the RLB contained 43 different linked probes, including the probes that could bind to all the Anaplasma, Ehrlichia, Babesia and Theileria DNA. This membrane is placed in a miniblotter in such a way that the slots that will later be filled with PCR products are perpendicular to the linked probe lines. 







A total of 47 dog owners agreed to let their dog participate in the research. Out of those 47 owners 8 owners did not show up for the second consultation (first follow up appointment).  Four of these owners were not available to participate in the second stage of the research for personal reasons. The remaining 4 owners had dogs which had died or were humanely euthanized. The exact causes for euthanasia or death were not thoroughly investigated. No postmortem necropsy was performed on these dogs. 
The clinical symptoms that were exhibited by the dogs just before death/ euthanasia are summed up here: 

1.	Died after three days of intensive care following days of gastrointestinal symptoms which were thought to be caused by an infection with Parvo virus. 
2.	Died suddenly after 2 days of treatment without an obvious cause.
3.	Euthanized after 3 days because of unrelated causes: this dog was infected with heartworm , had signs of cardiac decompensation (ascites, dyspnea,) and was suspected of having lymphoma. 
4.	Euthanized by choice of the owner during the first follow up because this dog was cachectic, lethargic, had jaundice and the dog was anorexic for more than a week ( it needs to be mentioned that this dog missed the last oxytetracycline shot and also did not receive the oral medication prescribed). 

Three of the remaining 39 dogs were unavailable for the last stage of the research. Out of those three dogs:
o	One dog ran away from home and was not found again.
o	One dog’s owner was unreachable for the last part of the research. 
o	One dog died, this dog had been treated for Heartworm 3 weeks before it died. The dog had some complications in the week after the Heartworm treatment which consisted of dyspnea, lethargy and fever. The dog eventually recovered but died 2 weeks later at home. The symptoms that the dog was having before it died were explained by the owner over the telephone, so the exact symptoms were not really clear. The owner could only explain that the dog was lethargic, anorexic and was vomiting stomach contents mixed with blood










% of dogs during the first, second and third consultation displaying certain clinical signs
	Lethargy 	Emaciation	Anorexia	Pu/Pd	Fever	Dyspnea	Oculo/nasal discharge	Pale mucous membranes
% of 47 dogs Consultation 1	79	45	60	6.4	47	6.4	11	45
% of 39 dogs Consultation 2	0	2.6	5.1	0	5.1	5.1	0	10
% of 36 dogs Consultation 3	0	0	0	0	5.6	0	0	2.8

	Gen.Lymph-adenomegaly	Petechiae	Hemorrhage	Jaundice	Ascites	Spleno-megaly	Artritis
% of 47 dogs Consultation 1	36	6.4	15	2.1	6.4	28	4.3
% of 39 dogs Consultation 2	36	0	0	0	0	10	0
% of 36 dogs Consultation 3	36	2.8	0	0	0	2.8	0

After taking the blood sample of the dogs during the first, second and third consultation; the hematocrit was measured. The norm for anemia was set at a hematocrit of 37% and lower. These results are depicted in table 2 below:
		
Table 2:
Percentage of anemic dogs during the first, second and third consultation	
Consultation	Anemic Patients (%)
First consultation	80.85
First control (second consultation)	48.72




1.	A total of 47 blood samples were collected during the first consultation. Out of those 47 samples, 23 tested positive for E.canis antibodies in the Snap® 3Dx® test. Out of the 23 positive blood samples, 4 blood samples belonged to dogs that were younger than 4 months old. To make sure that the test did not react to maternal antibodies, the test was repeated on the blood samples of three dogs at 4 and 8 weeks later (one owner of a participating dog did not show up for personal reasons). The results of the three tests that were repeated showed that two of the dogs remained positive and that the other one tested negative 4 weeks later and remained negative 8 weeks later as well. This proved that the dog which tested negative for the second and third consultation had maternal antibodies during the first consultation.
This concludes that 22 out of the 47 blood samples had a positive serological response (46.80%) to E.canis during the first consultation.
Out of the 47 blood samples, no blood samples were positive for Borrelia Burgdoferi antibodies. 
Out of the 47 blood samples, there were 8 dogs which tested positive for Dirofilaria immitis antigen (17%). 

2.	A total of 24 dogs which tested negative for E.canis antibodies remained for the second consultation. 4 of those dogs did not show up for the first follow up appointment (1 dog died and 3 owners were not available). So a serological test was done on 20 blood samples taken during the second consultation. Out of those 20 blood samples, 8 tested positive for E.canis antibodies. The dog which tested positive because of maternal antibodies (mentioned above) was also taken into account, so there were 21 serologically negative dogs available for the first control consultation, 8 of which had undergone a seroconversion.






There were a total of 16 dogs that fell under the treatment protocol one; puppies younger than 6 months being suspected of carrying the disease. This treatment consisted of once daily subcutaneous injections of oxytetracycline for 5 days.
Three dogs did not show up for the first follow up appointment:
o	One finished the treatment but did not show up for the first follow up appointment.  
o	One died suddenly after 2 days of treatment, the owner was not able to explain any symptoms accept anorexia and lethargy. 
o	One received 2 days of treatment and did not show up for the first follow up appointment.
One of the dogs that did show up for the first follow up appointment, did not finish the complete treatment protocol because of a communication error. The owner of the dog only showed up for 4 days of treatment. 

Two dogs did not show up for the second follow up appointment because 
-	One dog ran away from home and got lost.
-	The other dog’s owner was unreachable for the last consultation. 
	
The clinical signs exhibited during the first consultation of the 16 patients which fell under treatment protocol one, and the possible clinical improvement for the 13 (2nd consultation) and 11 (3rd consultation) patients is shown in table 3 below.  

Table 3:
% of dogs from Treatment protocol 1 displaying certain clinical signs 
	Lethargy 	Emaciation	Anorexia	Pu/Pd	Fever	Dyspnea	Oculo/nasal discharge	Pale mucous membranes
% of 16 dogs Consultation 1	75	44	69	6.3	50	6.3	0	56
% of 13 dogs Consultation 2	0	0	0	0	7.7	0	0	0
% of 11 dogs Consultation 3	0	0	0	0	0	0	0	0

	Gen.Lymph-adenomegaly	Petechiae	Hemorrhage	Jaundice	Ascites	Spleno-megaly	Artritis
% of 16 dogs Consultation 1	50	6.3	0	0	19	44	0
% of 11 dogs Consultation 2	31	0	0	0	0	15	0





There were a total of 18 dogs which fell under treatment protocol two; dogs older than 6 months being suspected of carrying the disease but having a hematocrit higher than 30%. 
This treatment consisted of once daily subcutaneous injections of oxytetracycline  for two consecutive days followed by oral doxycycline twice daily for 14 days. 
Two of these dogs did not show up for the first follow up appointment:
o	Finished the treatment but did not show up for the follow up appointment
o	Did not show up for the second subcutaneous injection and did not receive the oral doxycycline therapy.

Out of the remaining 16 dogs that did show up for the follow up appointment 5 owners followed an alternative treatment option either because of communication failure or personal preference. 
o	One dog was treated with one s.c injection of oxytetracycline followed by 10 days of oral doxycycline therapy. . 
o	One dog only received one s.c oxytetracycline injection and did not receive the 14 days or oral doxycycline either. This was caused by a communication failure.
o	One dog received three daily s.c oxytetracycline injections and 14 days of oral doxycyline treatment. This was also caused by a communication error. 
o	Two dogs were treated with one s.c injection of oxytetracycline followed by 14 days of oral doxycycline treatment. Only one s.c injection was given by the veterinarian because these dogs presented for an operation and were not clinically ill. One of these dogs had a low RBC count during a preoperative standard blood test, and the second dog had what seemed to be a coagulation problem during surgery. Because they were not clinically ill the veterinarian did not deem a second s.c injection necessary.

The clinical signs exhibited during the first consultation of the 18 patients which fell under treatment protocol two and the possible clinical improvement for the 16 remaining patients is shown in table 4 below.

Table 4: 
% of dogs from Treatment protocol 2 displaying certain clinical signs 
	Lethargy 	Emaciation	Anorexia	Pu/Pd	Fever	Dyspnea	Oculo/nasal discharge	Pale mucous membranes
% of 18 dogs Consultation 1	78	33	56	5.6	56	5.6	22	11
% of 16 dogs Consultation 2	0	0	0	0	0	0	6.3	0
% of 16 dogs Consultation 3	0	0	0	0	0	0	0	0

	Gen.Lymph-adenomegaly	Petechiae	Hemorrhage	Jaundice	Ascites	Spleno-megaly	Artritis
% of 18 dogs Consultation 1	11	5.6	17	0	0	22	11
% of 16 dogs Consultation 2	37.5	0	0	0	0	0	0




There were a total of 13 dogs which fell under treatment protocol three. Out of those 13 dogs there were three dogs that did not show up for the first follow up appointment. All three of these dogs died or were euthanized:
o	One dog died after receiving five s.c oxytetracycline injections and 4 days of oral doxycycline therapy. This dog died despite three days of intensive care, after exhibiting severe gastrointestinal symptoms and dehydration thought to be caused by a parvo virus infection.
o	One dog was euthanized after receiving one s.c oxytetracycline injection. The dog was euthanized because he had signs of decompensatio cordis (positive for Heartworm) and was also suspected of having lymphoma. 
o	The owner of one dog only showed up for the first four s.c oxytetracycline injections and did not pick of the oral doxycycline therapy. This dog was euthanized by choice of the owner after 4 weeks (just before the first follow up appointment) showing signs of anorexia for more than a week, extreme cachexia and Jaundice.

Out of the remaining 10 dogs that did show up for the first follow up appointment, 5 dogs received an alternative treatment. This alternative treatment was chosen for convenience by the veterinarian in deliberation with the owner.
o	One dog received one s.c oxytetracycline injection followed by 21 days of oral doxycycline therapy.
o	Two dogs received three s.c oxytetracycline injections followed by 14 days of oral doxycycline therapy. 
o	Two dogs received four s.c oxytetracycline injections followed by 14 days of oral doxycycline therapy. 

There was one dog that did not show up for the last appointment because the dog died at home after having had complications from heartworm treatment 2 weeks before.  
	
The clinical signs exhibited during the first consultation of the 13 patients which fell under treatment protocol three and the possible clinical improvement for the 10 (2nd consultation) and 9 (3rd consultation) patients is shown in table 3 below

Table 5:
% of dogs from Treatment protocol 3 displaying certain clinical signs 
	Lethargy 	Emaciation	Anorexia	Pu/Pd	Fever	Dyspnea	Oculo/nasal discharge	Pale mucous membranes
% of 13 dogs Consultation 1	85	62	54	7.7	31	7.7	0	77
% of 10 dogs Consultation 2	0	10	20	0	10	20	0	30
% of 9 dogs Consultation 3	0	0	0	0	22	0	0	11

	Gen.Lymph-adenomegaly	Petechiae	Hemorrhage	Jaundice	Ascites	Spleno-megaly	Artritis
% of 13 dogs Consultation 1	54	7.7	31	7.7	0	15	0
% of 10 dogs Consultation 2	40	0	0	0	0	10	0
% of 9 dogs Consultation 3	44	11	0	0	0	11	0


Finally the percentage of anemic patients (Hematocrit <38 %) per treatment protocol and possible improvement of the Hematocrit were also examined for the first, second and third consultation.

Table 6:
% anemic dogs and mean Ht (% ) per treatment protocol group and consultation.
	Protocol 1 	Protocol 2	Protocol 3
First consultation	100%     (mean: 28%)	50%       (mean: 37%)	100%       (mean: 24%)
Second consultation	77%       (mean: 34%)	19%       (mean: 43%)	60%         (mean: 36%)
Third consultation	64%       (mean: 36%)	12.5       (mean: 44%)	44%         (mean: 38%)


PCR/ Gel electrophoresis 
Ehlichia/Anaplasma catch all:
1.	Out of the 47 blood samples taken during the first consultation, only one blood sample (2.13%) had a positive signal for Ehlichia/Anaplasma catch all. 
2.	Out of the 39 blood samples taken during the first follow up consultation there were no blood samples which had a positive Ehrlichia/Anaplasma catch all signal.
3.	Out of the 36 blood samples taken during the second follow up consultation there was one blood sample (2.78%) which had a positive Ehrlichia/Anaplasma catch all signal.  

Babesia/Theileria catch all: 
1.	Out of the 47 blood samples taken during the first consultation there were a total of three blood samples (6.38%) which tested positive for the Babesia/Theileria catch all signal. 
2.	Out of the 39 blood samples taken during the first follow up consultation there was one blood sample (2.56%) which had a positive Babesia/Theileria catch all signal.
3.	Out of the 36 blood samples taken during the second follow up consultation there were no blood samples which tested positive for the Babesia/Theileria catch all signal.  


Reverse line blot (RLB)
First consultation:
Out of the 47 blood samples, 8 samples had a positive RLB signal. The RLB signal results in comparison with the PCR/gel results can be viewed below in table 7. 

Table 7:
PCR/Gel results and RLB signals (corresponding to a species) for 8 blood samples during the first consultation.

	PCR/ GelEhrl/Ana. Catch all	PCR/ GelBab/TheilCatch all. 	RLBEhrl/Ana signals	RLB Bab/Theil signals
Dog 1	Neg	Neg	- None	- Bab/Theil catch all- Bab catch all- Bab vogeli
Dog 2	Neg	Neg	- Ehrl/Ana catch all- E.canis/E. ovina	- None
Dog 3	Neg	Pos	-  None	- Bab/Theil catch all- Bab catch all- Bab vogeli
Dog 4	Neg	Neg	- None	- Bab/Theil catch all- Bab catch all- Bab vogeli
Dog 5	Neg	Neg	- None	- Bab/Theil catch all- Bab catch all- Bab vogeli
Dog 6	Neg	Pos	- None	- Bab/Theil catch all- Bab catch all- Bab vogeli
Dog 7	Pos	Pos	- Ehrl/Ana catch all- Anaplasma phagocytophilum	- Bab/Theil catch all- Bab catch all- Bab vogeli
Dog 8	Neg	Neg	- None	- Bab/Theil catch all- Bab catch all

Ehrlichia/Anaplasma species:
Out of the 47 blood samples taken during the first consultation, only two samples had a positive Ehrlichia/Anaplasma catch all signal on the RLB. Out of those 2 samples, one sample was positive for E.canis/E.ovina and one was positive for Anaplasma phagocytophilum. So out of the 47 blood samples from suspected CME patients only one blood sample had a positive E.canis RLB signal (2.13%).  

Babesia/Theileria species:
Out of the 47 blood samples taken during the first consultation, 7 samples had a positive signal for Babesia/Theileria catch all. All 7 of these samples had a Babesia catch all signal (there were no Theileria species present). Out of the 7 positive Babesia catch all signals only one sample was not further differentiated into a more specific Babesia species. The other 6 samples were all identified as positive Babesia canis vogeli RLB signals. 
So out of the 47 blood samples from suspected CME patients 6 blood samples were positive for Babesia canis vogeli (12.78%) and 1 blood sample was positive for a undifferentiated Babesia species (2.13%) . 

Second consultation (first follow up):
Out of the 39 blood samples, 3 had a positive RLB signal. The RLB signal results in comparison with the PCR/gel results can be viewed below in table 2.

Table 8:
PCR/Gel results and RLB signals (corresponding to a species) for 3 blood samples during the second consultation. (Dog # not related to dog # in table 1)

	PCR/ GelEhrl/Ana. Catch all	PCR/ GelBab/TheilCatch all 	RLBEhrl/Ana signals	RLB Bab/Theil signals
Dog 1	Neg	Pos	- None	- Bab/Theil catch all- Bab catch all- Bab vogeli
Dog 2	Neg	Neg	-None	- Bab/Theil catch all- Bab catch all- Bab vogeli
Dog 3	Neg	Neg	-None	- Bab/Theil catch all- Bab catch all- Bab vogeli

Ehrlichia/Anaplasma species: 
Out of the 39 blood samples taken during the second consultation, there were no blood samples in which a positive Ehrlichia/Anaplasma catch all RLB signal (0%) could be found.  

Babesia/Theileria species:




Out of the 36 blood samples, 1 had a positive RLB signal. The RLB signal result in comparison with the PCR/gel result for this blood sample is shown below in table 3.

Table 9:
PCR/Gel result and RLB signal (corresponding to a species) for blood sample during the third consultation (Dog # not related to dog # in table 1 or 2) 

	PCR/ GelEhrl/Ana. Catch all	PCR/ GelBab/TheilCatch all 	RLBEhrl/Ana signals	RLB Bab/Theil signals
Dog 1	Pos	Neg	- Ehrlichia/Anaplasma catch all	- None

Ehrlichia/Anaplasma species:
Out of the 36 blood samples taken during the third consultation, one sample had a positive Ehrlichia/Anaplasma catch all RLB signal (2.78%). This positive sample was from a dog which was had previously been negative for Ehrlichia/Anaplasma DNA. No further differentiation signals were exposed by the RLB that would classify the sample as positive for either Ehrlichia or Anaplasma DNA. 

Babesia/Theileria species:






5.1 CME Diagnostic Efficiency 
Only one out of the 47 blood samples (2.1%) taken from suspected CME patients during the first consultation, was found to be positive for E.canis DNA by PCR amplification and RLB detection. This amount seems very low because most dogs were exhibiting symptoms frequently seen in CME and most dogs clinically reacted well to treatment. This low amount of positive samples could either be due to:
1.	A very low E.canis infection level and so a definite over diagnosis of CME.
2.	An insensitive method of DNA fixation or extraction technique.
3.	An insufficient amount of blood tested.
It is unlikely to be due to the PCR amplification step or the Gel electrophoresis /RLB detection methods because these same methods and materials have been used frequently and successfully by the Utrecht centre for tick borne diseases for the detection of E.canis DNA in extracted DNA from either blood samples or ticks (Straten van der, G. 2008). 
The fact that Ehrlichia/Anaplasma DNA was extracted and amplified in two out of the 47 blood samples (and Babesia DNA in 7/47 blood samples) using the exact same method of DNA fixation and extraction makes it unlikely that these techniques were insensitive. 

There is no way of determining whether the low positive DNA samples were due e over diagnosis or if it was caused by a too small amount of blood that was tested. But it can be hypothesized; that the choice for the testing of blood and the amount of blood tested played a factor in the low amount of positive samples. 
This is explained below:

In a study by Harrus et al. that was publicized in 2004, DNA was extracted from 200 µl of blood, and from 50 µl of splenic aspirates collected from 5 acutely ill, E.canis inoculated dogs. After doxycycline treatment the blood was cleared of E.canis DNA at 9 days post treatment but the splenic aspirates of three of the 5 dogs were still positive (Harrus 2004). In another study done by Harrus et. al. in 1998, 6 dogs that were inoculated with E.canis 34 months before were tested for E.canis DNA. DNA was extracted from blood samples (250 µl) and splenic aspirates. Four of the six dogs had a positive E.canis PCR result on the splenic samples, but only two of those PCR positive dogs had positive PCR blood samples (Harrus et. al. 1998). These publications prove that the spleen is a more sensitive organ to detect E.canis DNA and that a negative blood sample does not mean the dog is not infected. 
There have been no publications about the amount of blood needed to detect E.canis DNA in acutely infected dogs. The amount of blood used for the detection of E.canis DNA in acutely infected dogs in the study by Harrus et. al. mentioned above, was 200 µl. In this research about 250 µl was fixated on filtration paper (blood spot), but as the DNA extraction protocol mentioned only about 20 -30 mm2 was cut out and used for extraction. The 20-30 mm2 used was about one third of the total blood spot, this corresponds to about 80 µl of blood used for the DNA extraction. So a low amount of positive blood samples could have been caused by the fact that a smaller amount of DNA was actually extracted. In other words even if the E.canis DNA was present in the blood, not enough of the blood was used to extract a sufficient amount of E.canis DNA that could be amplified by the PCR. 
An argument which supports this hypothesis about the amount of blood comes from the results of the serological tests conducted on the blood samples. During the first consultation, there were a total of 24 dogs which tested negative on the Idexx Snap 3Dx test for E.canis antibodies. 21 out of the 24 dogs were available for the first follow up consultation, 8 of these 21 blood samples were positive on the Idexx Snap test. This means that at least 8 dogs had undergone a seroconversion for E.canis during the first month after the consultation. The only dog which was positive on PCR for an E.canis infection was one of the 8 dogs which had seroconverted. According to Idexx-industries the sensitivity of the Snap 3-Dx test is 99% and the specificity is 100%. Because the specificity is 100%, you do not expect any false positive results. This would mean that it is extremely likely that the other 7 dogs which had undergone a seroconversion would have been infected during the first consultation.     
So because there is only speculation about the amount of suspected CME patients which were actually infected, nothing can be said about the efficiency of the CME diagnostic method used in Aruba. Nor can anything be said about specific symptoms or hematocrit results which may or may not be linked to CME.  The only definite result is that there were 13 out of the 47 dogs which did not undergo a seroconversion during the first month. The chance that one of the blood samples had a false negative result on the Snap-3 Dx test is only one percent.
In other researches, where dogs were experimentally infected with E.canis, almost all dogs displayed a seroconversion detected by IFA, within 20 days post inoculation (Harrus et. al., 1998, Buhles et. al. 1974). The incubation period for E.canis is ranges from 8-20 days, so it is to be expected that E.canis infected dogs exhibiting clinical symptoms would have definitely seroconverted within one month. Thus it can be concluded that these dogs which did not seroconvert were probably not infected with E.canis. So according to the Snap 3-Dx test at least 28% of the suspected CME patients were misdiagnosed.  


5.2 Analysis of the uninfected dogs
Nothing can be said about the characteristic clinical symptoms displayed by CME patients. But the clinical symptoms and hematocrit results of the13 uninfected dogs can be analyzed. The percentage of uninfected dogs displaying certain clinical symptoms and anemia in comparison with the total percentage of the suspected CME patients are depicted in table 10 below.

Table 10:
% of uninfected dogs and % of all participating dogs depicting certain clinical symptoms and anemia during the first consultation
	Lethargy 	Emaciation	Anorexia	Pu/Pd	Fever	Dyspnea	Oculo/nasal discharge	Pale mucous membranes
% of 13 uninfected dogs  	85	31	69	0	38	0	15	23
% of 47 participating dogs	79	45	60	6.4	47	6.4	11	45

	Gen.Lymph-adenomegaly	Petechiae	Hemorrhage	Jaundice	Ascites	Spleno-megaly	Artritis	Anemia
% of 13 uninfected dogs  	31	0	0	0	0	23	0	77
% of 47 participating dogs	36	6.4	15	2.1	6.4	28	4.3	81

When comparing the clinical symptoms presented by the uninfected dogs with the overall clinical symptoms displayed by the total suspected CME patients (including the uninfected) hardly any significant differences can be seen between the two categories. The only significant difference is the hemorrhage which is higher in the total CME suspected patients than those not infected. The fact that there are hardly any differences between the two categories can be explained by the fact that other than the thrombocytopenia and the bleeding tendencies (chronic phase) there are very few clinical symptoms in CME which are characteristic. 
So if a presumptive diagnosis is based upon only the clinical symptoms and the hematocrit presented by patients, it is to be expected that some over diagnosis will take place. This is why it can be advisable to combine the clinical symptoms with paired serological testing and more extensive blood analysis like a thrombocyte count. 
For dogs that will be imported from Aruba to the Netherlands or other countries where E.canis is not endemic, it might be relevant to additionally check for thrombocytopenia, this is often the only hematological change for dogs in the subclinical phase of CME (Harrus et. al 1, 1998). 

In the veterinary practice of Aruba it is often the combination of certain clinical symptoms and anemia which respond well to treatment which make the diagnosis CME probable. According to the dog owners all these uninfected dogs reacted well to treatment initially. At the first control appointment all but one uninfected dog had a significant clinical improvement. One dog still had a fever, generalized lymphadenomegalie, splenomegalie and anemia. A new treatment regimen was started for this dog because a reinfection with E.canis was suspected (the second serological test result was still unknown). This dog was not available for the last part of the research because it had walked away from home and gotten lost. But other than this dog the remaining 12 uninfected dogs had a significant clinical improvement at the first control consultation. One of these dogs however reacted well clinically but still had a very low Ht at the first control consultation, this dog was then treated for heartworm but died 2 weeks later from complications. 
The fact that most uninfected dogs clinically reacted well to treatment could mean that the clinical symptoms like fever, anorexia, lethargy and generalized lymphadenomegalie depicted by the uninfected dogs were probably caused by some other infection that was sensitive to either oxytetracycline or doxycycline. It is also possible that the immune systems of the dogs had cleared the infection themselves.      

The percentage of anemic patients in the uninfected dog group, although mild, is unusually high. The percentage of anemic patients including the mean hematocrit (Ht) of the uninfected dog group in reaction to treatment is shown in table 11 below. 

Table 11:
Percentage anemic dogs and mean Ht of uninfected dogs per consultation (pre treatment and post treatment)
	% Anemic dogs	Mean Ht. 
Consultation 1 (pre treat.)	77% (10/13 dogs)	34%
Consultation 2 (4 weeks post treat.)	62% (8/ 13 dogs)	37%
Consultation 3 (8 weeks post treat.)	27% (3/11 dogs)	40%

The table shows that the mean hematocrit rose and that the percentage of anemic dogs was lower in the uninfected dog group, after combination treatments with doxycycline and oxytetracycline.  
The cause of the anemia in these dogs was never examined further, especially because most dogs clinically reacted well to treatment. Although the amount of patients tested was to low to detect a significant difference, the fact that the percentage of anemic patients tend to go down and that the mean hematocrit seemed to improve might suggest other infections which react to the treatment. In two (15%) of these 13 dogs a positive PCR blood sample for B.canis vogeli was found, both of these dogs reacted positively to treatment (clinically as well as an elevation in Ht). But for the rest of the uninfected dogs no obvious correlation could be found for the anemia and why these dogs positively reacted to treatment, other than a non-specific chronic infection which can depress erythropoësis. 


5.3 Treatment efficiency 
There was only one blood sample which tested positive for E.canis on the RLB detection method. This dog fell under treatment protocol two but did not show up for the second subcutaneous oxytetracycline injection and did not receive oral doxycycline treatment. At first it was discussed to discard the blood sample because the owner did not fulfill the treatment protocol, but in the end it was decided to keep the blood sample for diagnostic reasons and to test if the immune system itself could clear the infection. The second and third blood samples from this dog were negative on the RLB, this could mean that the dog’s immune system had cleared the infection or that there was not enough DNA extracted from the second and third blood samples. During the first consultation this dog was anorexic, lethargic and had a fever, clinically the dog recovered well and had a rise in his Ht from 40% during the first consultation to 49% during the second follow up. During the second follow up it was noticed that the dog had generalized lymphadenomegaly, It is impossible to say whether this was caused by E.canis. 
Because of the few positive blood samples nothing can be said about the efficacy of the treatment used in the veterinary practice.


5.4 Significance of B.canis vogeli infections
Babesia canis and Babesia gibsoni have been recognized worldwide as the two species that can cause canine babesiosis. Morphologically these two can be differentiated by size: B. canis is a large piroplasm (4-5µm) and B. gibsoni is a small piroplasm (1.2- 2.5 µm) (Caccio et. al., 2002). In 1989 Uilenberg et. al. realized that the large piroplasm B.canis could be divided into three different subspecies, on the basis of differences in antigenic properties and vector specificity; B. canis canis transmitted by Dermacentor reticulatus in Europe, B. canis rossi transmitted by Haemophysalis leachi in South Africa and B.canis vogeli transmitted by Rhipicephalus sanguineus in tropical and subtropical countries (Uilenberg et. al. 1989, Caccio et. al., 2002).
Since 1989 efforts to molecularly detect B.canis vogeli infections in dogs have steadily risen. Until now the B.canis vogeli infection has been detected in countries like: South- and North Africa, Brazil, Australia, Slovenia, France and Spain (Duh et. al. 2004, Brown et. al. 2006, Passos et. al. 2004, Matjila et. al. 2004). 
Most publications about B. canis vogeli infections in dogs, have reported that unlike the other B.canis subspecies and B. gibsoni species which can cause obvious clinical symptoms (anemia, fever, anorexia, depression and pale mucous membranes), B.canis vogeli usually causes a mild often clinically unapparent disease (Uilenberg et. al. 1989). But in a report by Brown et. al. in which free roaming dogs in Australia were screened for the presence of B. canis vogeli  and  A.platys, a positive correlation with thrombocytopenia was found in 33% of  dogs PCR positive for B.canis vogeli (Brown et. al. 2006). In another report by Duh et. al in 2004, blood samples of 238 dogs showing clinical signs compatible with canine babesiosis were analyzed, 3 of these blood samples were positive for B.canis vogeli on PCR. The patient information was supplied for two of these dogs, one dog was admitted for chronic cough and had no blood tests done, the other dog was admitted for depression, anorexia and fever and had an obvious thrombocytopenia (19× 109 PLT’s /L)( Duh et. al. 2004). 
Because of the fact that canine babesiosis is clinically hard to differentiate from CME, Babesia canis vogeli infections causing clinical symptoms in dogs like the ones mentioned in the article by Duh et. al. might also be misdiagnosed for CME. This difficulty has been reproduced in a study by Matjila et .al in 2004; one dog (showing symptoms of CME) from an area in South Africa where E.canis is endemic, was admitted to the Onderstepoort Veterinary Academic Hospital suspected of ehrlichiosis, the blood sample was tested and was actually found to be positive for Babesia canis vogeli (Matjila et. al., 2004). The clinical symptoms exhibited by the suspected dog were not mentioned in the article.     
Five of the six dogs that were positive for B.canis vogeli during the first consultation were found negative during the subsequent consultations. During the second consultations there were two new dogs that were infected with B.canis vogeli, none of these dogs were positive for the last consultation. This suggest that the host can probably clear the infection on it’s own but it can also be proposed that the treatment used for CME could assist in the clearance of B.canis vogeli infections. 
Until now there have been no publications about the treatment of B.canis vogeli infections probably because it does not cause significant disease.  Many different treatment options have been proposed for B.canis canis or B.canis rossi infections (Boozer et. al., 2003). Although tetracyclines are not recommended for the treatment of clinical babesiosis, oral doxycycline (5 mg/kg/day and 20mg/kg/day) has been used effectively in the prophylactic treatment of dogs challenged with pathogenic strains of Babesia canis (Vercammen et. al., 1996). So it can be hypothesized that the oxytetracycline/ doxycycline treatment used for CME, can assist in the clearance of B. canis vogeli infections and thus mask its clinical significance on Aruba.   

5.4 Anaplasma phagocytophilum
One of the blood samples during the first consultation was found to be positive for A.phagocytophilum on the RLB detection method. This 5 month old dog had severe clinical symptoms; the dog was lethargic, emaciated, had generalized lymphadenomegaly, pale mucous membranes (Ht: 18%) and had mild intermittent bloody diarrhea. The dog was treated with oxytetracycline for 5 consecutive days and was given doxycyline for 14 days. The diarrhea remained mild and intermittently bloody. The dog returned three days after the start of treatment expressing signs of severe dehydration, severe bloody diarrhea and vomiting; the dog was admitted to the intensive care unit where it received an I.V drip and antibiotics (Trimethoprim/sulfadoxine and oxytetracycline). The dog died despite three days of intensive care. 
Anaplasma phagocytophilum is a newly designated tickborne pathogen which joins together three previously described species: Ehrlichia phagocytophila, E.equi, and human granulocytic ehrlichiosis agent because of a high degree of similarities between the 16S RNA genes of these Ehrlichia species. A.phagocytophila can infect many different species including dogs, cats, horses, cattle, sheep, rodents and humans (Poitout et. al. 2005). A. phagocytophilum is transmitted by ticks of the Ixodus species, within as well as between the animal species mentioned above. (Poitout et. al. 2005, Dumler et. al. 2005). Until now there have been no publications to suggest that A.phagocytophilum can be transmitted by R.sanguineus ticks. This finding might suggest the possibility that other tick species may play a role in the transmission of disease in the dog population of Aruba. Or it might suggest that R.sanguineus can play a role in the transmission of A. phagocytophilum.
A.phagocytophilum infection in dogs can cause subclinical disease or an acute febrile infection accompanied by lethargy, anorexia, fever, lameness, pale mucous membranes and respiratory symptoms. The most consistent hematological change is a mild thrombocytopenia, although leucopenia, lymfocytopenia and a mild anemia can also be seen (Lester 2005, Poitout 2005). Although the symptoms and hematological changes mimic an E.canis infection, they are usually milder in an A.phagocytophilum infection (Lester 2005).  
The treatment of an A.phagocytophilum infection can also consist of Doxycyline or Tetracycline antibiotics. This treatment for 21 days usually clears the infection (Poitout et. al.). 





In this research only 1 out of the 47 suspected CME dogs was positive for E.canis.
Although over diagnosis can not be excluded, the low amount of blood samples which tested positive for E.canis was probably due to the insufficient amount of blood tested, but this is impossible to verify. Based on serological testing 13 out of the 47 dogs (28%) thought to be infected during the first consultation were not, so there was definitely some over diagnosis of CME. A lot of these uninfected dogs were anemic, so for dogs only showing anemia without other typical CME signs(chronic form); it might be advisable to test for other hematological changes that are more specific for CME, especially thrombocytopenia. It might also be necessary to exclude other factors/diseases which can cause anemia. The use of paired serological testing is controversial, in many cases the blood sample taken during the first presentation of the patient could already be positive (chronic-, subclinical infection or infected and cleared in the past) which has no clinical significance. Another factor which plays a role; even when the first sample is negative the second sample will only be taken when most of the antibiotics will have already been taken (no savings of costs for the owner). The only significant result in paired serological testing is if the first and second tests are negative, then E.canis is less likely and other differential diagnosis should be followed up. So paired serological testing can be tried but it’s only effective in certain cases of CME, the decision to try these tests will be up to the Veterinarians as well as the owners. For dogs immigrating to other countries from Aruba with a history of CME, it is important to thoroughly check for ticks. It might also be advisable to use serological testing in order to prevent the trafficking of infected dogs and ticks into the Netherlands. 

Because of the few positive blood samples no conclusions could be made about the treatment affectivity. Because thrombocytopenia is the main hematological change in CME and also the first hematological change to improve after successful treatment, it is advisable to have a standard check up thrombocyte count before and after treatment.  

Furthermore, if more research is to be done on the presence of E.canis in blood samples, it will be important for sufficient blood to be used for DNA extraction. The method of fixation of the blood spots on filtration paper might not be an effective way of transporting larger amounts of blood for further DNA extraction. So in the future other methods of transportation of blood samples might need to be used (freezing and transporting whole blood).  

Most publications claim that B.canis vogeli only causes a mild often unapparent disease in dogs, but some publications have linked B.canis vogeli infections to thrombocytopenia and other CME like symptoms (Brown et. al. 2006, DUH et. al. 2004). To test the relevance of B.canis vogeli infections in the Aruban dog population, more research will be needed to determine the exact clinical and hematological effect of B.canis vogeli infections in dogs and the prevalence of B.canis vogeli among the Aruban dog population. It might also be interesting to check for the effect of co-infections with B.canis vogeli especially for areas where E.canis is endemic.











































































Blaauw, F., Het voorkomen van Ehrlichia canis en Rhipicephalus sanguineus in Europa en Nederland, March 2009,Research Report, pg. 1-16

Boozer, A.L., Macintire, K.M., Canine Babesiosis, July 2003, Veterinary Clinics of North America: Small Animal Practice, Vol. 33, Is.4, pg. 885-904

Breitschwerdt, E.B., Hegarty, B.C., Hancock, S.I., Doxycycline Hyclate Treatment of Experimental Canine Ehrlichiosis Followed by Challenge Inoculation with Two Ehrlichia canis Strains, February 1998, Antimicrobial Agents and Chemotherapy, Vol. 42, No. 2, pg. 362-368

Bremer, W.G., Schaefer, J.J., Wagner, E.R., Ewing, S.A., Rikihisa, Y., Needham, G.R., Jittapalapong, S., Moore, D.L., Stich, R.W., Transstadial and intrastadial experimental transmission of Ehrlichia canis by male Rhipicephalus sanguineus, July 2005, Veterinary Parasitology, Vol. 131, Iss. 1-2, pg. 95-105

Brown, G.K., Canfield, P.J., Dunstan,R.H., Roberts, T.K., Martin, A.R., Brown, C.S., Irving, R., Detection of Anaplasma platys and Babesia canis vogeli and their impact on platelet numbers in free-roaming dogs associated with remote Aboriginal communities in Australia, September 2006, Australian Veterinary Journal, Vol.. 84, No. 9, pg. 321-325

Buhles, W.C., Huxsoll, D.L., Ristic, M., Tropical Canine Pancytopenia: Clinical, Hemtaologic and Serologic Response of Dogs to Ehrlichia canis Infection, Tetracycline Therapy, and Challenge Inoculation, October 1974, Journal of Infectious Diseases, Vol. 130, No 4.
Matjila,T.P, Nijhof, A.M., Taoufik, A., Houwers, D., Teske, E., Penzhorn B.L., Lange, T., Jongejan, F., Autochthonous canine babesiosis in The Netherlands, July 2005, Veterinary Parasitology, Vol.. 131, Iss. 1-2, pg. 23-29 

Caccio,S.M., Antunovic,B., Moretti, A., Mangili, V., Marinculic, A., Baric, R.R., Slemenda, S.B., Pieniazek, N.J. Molecular characterization of Babesia canis canis  and Babesia canis vogeli from naturally infected European dogs, March 2008, Veterinary Parasitology, Vol. 152, Iss. 1-2, pg. 1-7

Dantas-Torrs, F., The brown dog tick, Rhipicephalus sanguineus: From taxonomy to control, April 2008, Veterinary Parasitology, Vol. 152, Iss. 3-4, pg. 173-185
Duh,D., Tozon, N., Petrovec, M., Strasek K., Avsic-Zupanc, T., Canine babesiosis in Slovenia : Molecular evidence of Babesia canis canis and Babesia canis vogeli, February 2004, Vet. Res., Vol. 35, pg. 363-368

Dumler, S.J., Choi, K., Garcia-Garcia, J.C., Barat, N.S., Scorpio, D.G., Garyu, J.W., Grab, D.J., Bakken, J.S., Human Granulocytic Anaplasmosis and Anaplasma phagocytophilum, December 27 2005, Emerging Infectious Diseases Vol. 11

Harrus, S., Waner, T., Aizenberg, I., Foley, J.E., Poland, A.M., Bark, H., Amplification of Ehrlichial DNA from Dogs 34 Months after Infection with Ehrlichia canis, January 1998, Journal of Clinical Microbiology, Vol. 36, No. 1, pg. 73-76
Harrus, S., Waner, T., Aizenberg, I., Bark, H., Therapeutic Effect of Doxycycline in Experimental Subclinical Canine Monocytic Ehrlichiosis: Evaluation of a 6-Week Course, July 1998, Journal of Clinical Microbiology, Vol. 36, No. 7, pg. 2140-2142 

Harrus, S., Waner, T., Bark, H., Jongejan, F., Cornelissen, A.W.C.A., Recent Advances in Determining the Pathogenesis of Canine Monocytic Ehrlichiosis, September 1999, Journal of Clinical Microbiology, Vol. 37, pg. 2745-2749

Harrus, S., Kenny, M., Miara, L., Aizenberg, I., Waner, T., Shaw, S., Comparison of Simultaneous Splenic Sample PCR with Blood Sample PCR for Diagnosis and Treatment of Experimental Ehrlichia canis Infection, November 2004, Antimicrobial Agents and Chemotherapy, Vol. 48, No. 11, pg.4488-4490
Iqbal, Z., Rikihisa, Y., Reisolation of Ehrlichia canis from blood and tissues of dogs after doxycycline treatment, July 1994, Journal of Clinical Microbiology, Vol.32 , pg. 1644-1649

Kaufhold, A., Podbielski, A., Baumgarten, G., Blokpoel, M., Top, J., Schouls, L., 1994. Rapid typing of group A streptococci by the use of DNA amplification and nonradioactive allele- specific oligonucleotide probes. FEMS Microbiology Letters, ver. 119: pg.19-25

Kremer,K., Zetten, van M., Embden, van J., Schouls, L., Soolingen, van D., RIFO assay; a PCR and reverse line blot hybridization method to detect rifampin resistance, 2003, National institute of public health and the environment, Bilthoven,Netherlands, pp: 15-16

Lester, S.J., Breitschwerdt, E.B., Collis, C.D., Hegarty B.C., Anaplasma phagocytophilum infection (granulocytic anaplasmosis) in a dog from Vancouver Island, September 2005, Canadian Veterinary Journal, Vol. 46, no 9 , pg: 825-827 

Matjila, P.T., Penzhorn, B.L., Bekker, C.P.J., Nijhof, A.M., Jongejan, F., Confirmation of occurrence of Babesia canis vogeli in domestic dogs in South Africa, June 2004, Veterinary Parasitology, Vol. 122, Iss. 2, pg. 119-125 

Neer, T.M., Breitschwerdt, E.B., Greene, Lappin, M.R., Consensus Statement on Ehrlichial Disease of Small Animals from the Infectious Disease Study Group of the ACVIM, 2002, Journal of Veterinary Internal Medicine, Vol. 16, No. 3, pg. 309-315  

Nelson, R.W., Couto, C.G., Canine Ehrlichiosis, 2003, Small Animal Internal Medicine 3rd ed., pg: 1267-1271 
Nijhof, A.M., Bodaan, C., Postigo, M., Nieuwenhuijs, H., Opsteegh, M., Franssen, L., Jebbink, F., Jongejan, F., Ticks and Associated Pathogens Collected from Domestix Animals in the Netherlands, 2007, Vector-Borne And Zoonotic Diseases Vol.. 7, No. 4, pg. 585-595

Passos, L.M.F, Geiger,S.M., Ribeiro, M.F.B., Zahler-Rinder, M., First molecular detection of Babesia vogeli in dogs from Brazil, Januari 2005, Veterinary Parasitology, Vol. 127, Issue 1, pg. 81-85

Poitout, F.M., Shinozaki, J.K., Stockwell, P.J., Holland, C.J., Shukla, S.K., Genetic Variants of Anaplasma phagocytophilum Infecting Dogs in Western Washington State, February 2005, Journal of Clinical Microbiology Vol. 43, No. 2, pg: 796-801

Rikihisa, Y., Yamamoto, S., Kwak, I., Iqbal, Z., Kociba, G., Mott, J., Chichanasiriwithaya, W., C-Reactive Protein and al-Acid Glycoprotein levels in Dogs Infected with Ehrlichia canis, April 1994, Journal of Clinical Microbiology, Vol. 32, No. 4, pg. 912-917


Smith,R.D., Ristis,M., Huxsoll, D.L., Baylor, R.A., Platelet kinetics in canine ehrlichiosis: evidence for increased platelet destruction as the cause of thrombocytopenia, June 1975, Infection and Immunity. Vol. 11, No. 6, pg. 1216-1221

Straten G., A survey of ticks, Ehrlichia canis and current control methods on dogs on the Island of Aruba, November 2008, Research report 
Uilenberg, G., Franssen, F.F., Perie, N.M., Spanjer, A.A., Three groups of Babesia canis distinguished and a proposal for nomenclature, January 1989, The Veterinary Quarterly, Vol. 11,No. 1, pg. 33-40

Vercammen, F., Deken, R., Maes, L., Prophylactic treatment of experimental canine babesiosis (Babesia canis) with doxycycline, March 18 1996, Veterinary Parasitology, Vol.. 66, pg. 251-255 









































Owner’s Name and Address:-------------------------------------------------------------------------------------------------------------






























Snap test result (date 1): 			Positive		Negative
Snap test result (date 2):			Positive		Negative
Snap test result (date 3):			Positive		Negative



PAGE  



2



